PERIMETER MEDICAL IMAGING AI, INC. Financials Perimeter Medical Imaging AI, Inc.
Equities
PINK
CA71385D1078
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7 CAD | +1.45% |
|
-9.09% | -42.62% |
| Apr. 22 | Perimeter Medical Imaging AI, Inc.(TSXV:PINK) dropped from S&P/TSX Venture Composite Index | CI |
| Apr. 16 | Transcript : Perimeter Medical Imaging AI, Inc. - Special Call |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 103.1 | 184.5 | 105.7 | 79.33 | 45.54 | - | - |
| Enterprise Value (EV) 1 | 103.1 | 184.5 | 105.7 | 79.33 | 45.54 | 45.54 | 45.54 |
| P/E ratio | -9.14 x | -10.8 x | -7.61 x | -4.1 x | -2.1 x | -1.94 x | -2.41 x |
| Yield | - | - | - | - | - | - | - |
| Capitalization / Revenue | 1,054 x | 2,044 x | 591 x | 145 x | 20.5 x | 3.86 x | 1.77 x |
| EV / Revenue | 1,054 x | 2,044 x | 591 x | 145 x | 20.5 x | 3.86 x | 1.77 x |
| EV / EBITDA | -13.3 x | -14.4 x | -5.51 x | -4.09 x | -2.4 x | -2.17 x | -2.73 x |
| EV / FCF | -12,472,645 x | -11,506,046 x | - | - | - | - | - |
| FCF Yield | -0% | -0% | - | - | - | - | - |
| Price to Book | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 38,891 | 44,999 | 64,459 | 65,026 | 65,053 | - | - |
| Reference price 2 | 2.650 | 4.100 | 1.640 | 1.220 | 0.7000 | 0.7000 | 0.7000 |
| Announcement Date | 4/30/21 | 5/2/22 | 4/11/23 | 3/29/24 | - | - | - |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 0.0978 | 0.0903 | 0.1789 | 0.5464 | 2.22 | 11.8 | 25.67 |
| EBITDA 1 | -7.768 | -12.84 | -19.18 | -19.4 | -19.01 | -20.96 | -16.65 |
| EBIT 1 | -10.06 | -16.06 | -22.31 | -22.02 | -20.68 | -22.34 | -18.32 |
| Operating Margin | -10,286.91% | -17,794.66% | -12,472.67% | -4,029.46% | -931.44% | -189.42% | -71.35% |
| Earnings before Tax (EBT) 1 | -7.886 | -16.65 | -13.35 | -19.01 | -21.1 | -22.9 | -18.87 |
| Net income 1 | -7.886 | -16.65 | -13.35 | -19.01 | -21.1 | -22.9 | -18.87 |
| Net margin | -8,062.54% | -18,446.63% | -7,461.48% | -3,478.29% | -950.23% | -194.13% | -73.51% |
| EPS 2 | -0.2900 | -0.3800 | -0.2156 | -0.2979 | -0.3330 | -0.3610 | -0.2910 |
| Free Cash Flow | -8.263 | -16.03 | - | - | - | - | - |
| FCF margin | -8,448% | -17,763.13% | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 4/30/21 | 5/2/22 | 4/11/23 | 3/29/24 | - | - | - |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 0.0233 | 0.0247 | 0.0255 | 0.0195 | 0.0559 | 0.0773 | 0.1503 | 0.1825 | 0.1184 | 0.0984 | 0.416 | 0.555 | 0.555 | 0.694 |
| EBITDA 1 | -3.332 | -3.771 | -4.213 | -4.991 | -4.979 | - | -4.666 | -4.146 | -5.165 | -5.573 | -4.857 | -4.857 | -4.719 | -4.719 |
| EBIT 1 | -3.725 | -5.504 | -4.823 | -6.107 | -5.815 | 0.655 | -5.076 | -4.38 | -6.062 | -6.626 | -5.274 | -5.274 | -5.135 | -5.135 |
| Operating Margin | -15,967.68% | -22,308.8% | -18,915.02% | -31,271.27% | -10,405.58% | 847.7% | -3,377.18% | -2,399.84% | -5,121.56% | -6,734.08% | -1,267.79% | -950.27% | -925.23% | -739.91% |
| Earnings before Tax (EBT) 1 | -3.88 | -5.517 | -6.449 | -0.3663 | -0.8185 | - | -4.444 | -6.662 | -0.4731 | -7.484 | -5.412 | -5.274 | -5.274 | -5.135 |
| Net income 1 | -3.88 | -5.517 | -6.449 | -0.3663 | -0.8185 | - | -4.444 | -6.662 | -0.4731 | -7.484 | -5.412 | -5.274 | -5.274 | -5.135 |
| Net margin | -16,631.68% | -22,363.8% | -25,290.47% | -1,875.58% | -1,464.8% | - | -2,956.87% | -3,650.3% | -399.66% | -7,605.67% | -1,300.96% | -950.27% | -950.27% | -739.91% |
| EPS 2 | -0.0900 | -0.1300 | -0.1100 | -0.0100 | -0.0100 | -0.0539 | -0.0682 | -0.1087 | -0.0137 | -0.1219 | -0.0830 | -0.0830 | -0.0830 | -0.0830 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/29/21 | 5/2/22 | 5/30/22 | 8/24/22 | 11/15/22 | 4/11/23 | 5/25/23 | 8/30/23 | 11/14/23 | 3/29/24 | - | - | - | - |
1CAD in Million2CAD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow | -8.26 | -16 | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - |
| Capex | - | - | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - | - | - |
| Announcement Date | 4/30/21 | 5/2/22 | 4/11/23 | 3/29/24 | - | - | - |
1CAD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
0.7
CAD
Average target price
4.375
CAD
Spread / Average Target
+525.00%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -42.62% | 33.26M | |
| -5.77% | 14.6B | |
| -40.71% | 2.71B | |
| -12.92% | 2.44B | |
| -8.78% | 1.51B | |
| -.--% | 1.12B | |
| +40.66% | 518M | |
| +11.68% | 239M | |
| +1.67% | 183M | |
| -.--% | 168M |
- Stock Market
- Equities
- PINK Stock
- Financials Perimeter Medical Imaging AI, Inc.
